You just read:

New Study Demonstrates Potential Cost Savings Associated with Use of IBSchek™ Diagnostic Blood Panel for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

News provided by

Commonwealth Laboratories, LLC

Jun 08, 2016, 12:00 ET